Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$79.4 - $116.36 $3,176 - $4,654
-40 Reduced 59.7%
27 $2,000
Q1 2022

May 02, 2022

SELL
$86.42 - $109.81 $6,567 - $8,345
-76 Reduced 53.15%
67 $7,000
Q4 2021

Feb 11, 2022

BUY
$98.56 - $119.91 $9,461 - $11,511
96 Added 204.26%
143 $15,000
Q1 2021

Apr 30, 2021

BUY
$71.83 - $95.48 $3,376 - $4,487
47 New
47 $4,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.